177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours : Results of the phase III NETTER-1 trial

Strosberg, J. (author)

Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Med Oncol & Hematol, Tampa, FL 33612 USA.

Wolin, E. (author)

Univ Kentucky, Markey Canc Ctr, GI Carcinoid & Neuroendocrine Canc, Lexington, KY 40506 USA.

Chasen, B. (author)

Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA.

show more...

Kulke, M. (author)

Dana Farber Canc Inst, Neuroendocrine & Carcinoid Tumors, Boston, MA 02115 USA.

Bushnell, D. (author)

Univ Iowa, Carver Coll Med, Div Nucl Med, Iowa City, IA USA.

Caplin, M. (author)

Royal Free Hosp, Gastroenterol & Gastrointestinal Neuroendocrinol, London NW3 2QG, England.

Baum, R. P. (author)

Ctr Neuroendocrine Tumors, Zent Klin, Bad Berka, Germany.

Mittra, E. (author)

Stanford Univ, Med Ctr, Radiol & Nucl Med, Stanford, CA 94305 USA.

Hobday, T. (author)

Mayo Clin, Coll Med, Hematol & Oncol, Rochester, MN USA.

Hendifar, A. (author)

Cedars Sinai Med Ctr, Gastrointestinal Oncol, Los Angeles, CA 90048 USA.

Öberg, Kjell (author)

Uppsala universitet,Institutionen för medicinska vetenskaper

Sierra, M. Lopera (author)

Adv Accelerator Applicat, Clin Dev, New York, NY USA.

Ruszniewski, P. (author)

Hop Beaujon, Gastroenterol & Pancreatol, Clichy, France.

Kwekkeboom, D. (author)

Erasmus MC, Nucl Med, Rotterdam, Netherlands.

show less...

Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Med Oncol & Hematol, Tampa, FL 33612 USA Univ Kentucky, Markey Canc Ctr, GI Carcinoid & Neuroendocrine Canc, Lexington, KY 40506 USA. (creator_code:org_t)

2015

2015

English.

In: European Journal of Cancer. - 0959-8049 .- 1879-0852. ; 51:S3, s. S710-S710

Related links:

https://urn.kb.se/re...

• Journal article (other academic/artistic)